risks of using semaglutide Semaglutide: Double-edged Sword with and Benefits Evaluating and managing semaglutide risk

Subscribe to our newsletter to get access today

doi: 10.1093/eurheartj/ehae568 53

If your region restricts import, check local customs rules before ordering and confirm cold-chain refrigerated delivery is available to your address

25 mg oral does not equal 2.4 mg injection. Oral semaglutide has low bioavailability, which is one reason dosing rules are strict (explained in the Rybelsus prescribing information) (FDA Rybelsus label, 2025)

individual results vary significantly Both medications require adherence to dosing schedule and lifestyle modifications Higher doses generally produce better results but may have more side effects Not everyone reaches maximum doses due to side effect tolerance Actual weight loss depends on starting weight, diet, exercise, and individual metabolism Time to See Results: Semaglutide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (5-8 pounds) Weeks 12-24: Steady weight loss (1-2 pounds per week) Weeks 24-68: Continued weight loss at slower pace Tirzepatide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (8-12 pounds) Weeks 12-24: Steady weight loss (1.5-2.5 pounds per week) Weeks 24-72: Continued weight loss, often at sustained pace Both medications show continued weight loss throughout the clinical trial periods, with weight loss plateauing around month 16-20 for most participants